Biol Psychiatry

1. VYAZOVSKIY VV, Bannerman DM
   Preclinical models for schizophrenia and sleep oscillations: from biomarkers to mechanisms.
   Biol Psychiatry. 2025 Apr 8:S0006-3223(25)01115.
   

   >> Share

   
   

   
   Br J Psychiatry

2. LYMAN M, Fanshawe JB, Brewin J, Fanshawe TR, et al
   Introduction of point-of-care blood testing in early intervention in psychosis services: effects on physical health screening.
   Br J Psychiatry. 2025 Apr 11:1-6. doi: 10.1192/bjp.2025.
   

   >> Share

   
   

   
   Brain Res

3. CHEN P, Hu H, Wang M, Li R, et al
   Modulating excitation of the mediodorsal thalamus rescues dysfunction after administration of MK-801 in rats.
   Brain Res. 2025;1855:149532.
   

   >> Share

   
   

   
   J Clin Psychiatry

4. TSAI SJ, Cheng CM, Chang WH, Bai YM, et al
   Effects of Parental Severe Mental Disorders on All-Cause and Suicide Mortalities in Adolescents and Young Adults With Major Depressive Disorder.
   J Clin Psychiatry. 2025;86:24m15476.
   

   >> Share

   
   
5. YEUNG PP, Breier A, Zhu H, Kaul I, et al
   Xanomeline and Trospium Chloride for the Treatment of Agitation Associated With Schizophrenia: PANSS-Excited Component Results From 3 Randomized, Double-Blind, Placebo-Controlled EMERGENT Trials.
   J Clin Psychiatry. 2025;86:24m15668.
   

   >> Share

   
   

   
   J Clin Psychopharmacol

6. FLANAGAN RJ, Obee SJ, Kim AHM, Every-Palmer S, et al
   Plasma Clozapine in Treatment Refractory Schizophrenia: What Is the Target Range?
   J Clin Psychopharmacol. 2025 Apr 9. doi: 10.1097/JCP.0000000000002007.
   

   >> Share

   
   
7. KIKUCHI Y, Sakata M, Ikawa K, Kume D, et al
   Weekly Changes in the Clozapine Concentration-to-Dose Ratio During Clozapine Titration in Japanese Patients With Schizophrenia.
   J Clin Psychopharmacol. 2025 Apr 7. doi: 10.1097/JCP.0000000000002003.
   

   >> Share

   
   

   
   Mol Psychiatry

8. HATZIPANAYIOTI A, Walther S, Gangl N, Conring F, et al
   Aberrant personal space is associated with paranoia, altered stress regulation, and unfavourable outcomes at 6 months' follow-up in schizophrenia.
   Mol Psychiatry. 2025 Apr 9. doi: 10.1038/s41380-025-02999.
   

   >> Share

   
   

   
   Psychiatry Res

9. SHAKER NM, Aly El-Gabry D, Abdel Aziz K, Hashem R, et al
   Clinical and neuroradiological differences in obsessive compulsive disorder with and without psychosis.
   Psychiatry Res. 2025;348:116472.
   

   >> Share

   
   
10. CAO C, Liu W, Hou C, Chen Y, et al
    Disrupted default mode network connectivity and its role in negative symptoms of schizophrenia.
    Psychiatry Res. 2025;348:116489.
    

    >> Share

    
    
11. LU J, Gou N, Zhang S, Zhou J, et al
    Dysfunctional striatal-temporal connectivity is associated with a higher risk for violence in patients with schizophrenia.
    Psychiatry Res. 2025;348:116488.
    

    >> Share

    
    
12. SIMGE UO, Burcu V, Aybuke K, Ezgi C, et al
    Clinical high risk for psychosis in bipolar disorder: Clinical features, cognition and functioning.
    Psychiatry Res. 2025;348:116478.
    

    >> Share

    
    
13. BAILEY A, Bauer BW, Mittal VA, Ellman LM, et al
    Interpersonal difficulties and suicidal ideation in young people at clinical high-risk for psychosis and help-seeking clinical controls.
    Psychiatry Res. 2025;348:116467.
    

    >> Share

    
    

    
    Psychol Med

14. CHEN YHE, Wong SMY, So MM, Suen YN, et al
    Spurious autobiographical memories of psychosis: a dopamine-gated neuroplasticity account for relapse and treatment-resistant psychosis.
    Psychol Med. 2025;55:e14.
    

    >> Share

    
    
15. RAMI FZ, Seo H, Kang C, Park S, et al
    Associations of polygenic risk score, environmental factors, and their interactions with the risk of schizophrenia spectrum disorders.
    Psychol Med. 2025;55:e111.
    

    >> Share

    
    
16. STRAKELJAHN F, Lincoln TM, Schlier B
    Predicting experiences of paranoia and auditory verbal hallucinations in daily life with ambulatory sensor data - A feasibility study.
    Psychol Med. 2025;55:e114.
    

    >> Share

    
    

    
    Schizophr Res

17. LIU M, Tian S, Liu X, Zhang H, et al
    Analysis of differentially expressed genes in schizophrenia based on bioinformatics and corresponding mRNA expression levels.
    Schizophr Res. 2025;280:22-29.
    

    >> Share

    
    
18. PATEL PK, Thies MB, Moyett A, Arkin S, et al
    Avolition predicts variability in optimal risk-taking in early psychosis.
    Schizophr Res. 2025;280:15-21.
    

    >> Share

    
    
19. FORTIER A, Tikasz A, Athanassiou M, Zouaoui I, et al
    Hippocampus subfield volume reductions in treatment-resistant schizophrenia.
    Schizophr Res. 2025;280:10-14.
    

    >> Share

    
    
20. MATHIS WS, Gibbs-Dean T, Cahill JD, Srihari VH, et al
    HONE: A learning health system platform for advancing early intervention in first episode psychosis.
    Schizophr Res. 2025;280:1-9.
    

    >> Share

    
    
21. GREVE AN, Hemager N, Piche G, Burton BK, et al
    Perceived social support in parents with schizophrenia or bipolar disorder and their co-parents: The Danish high risk and resilience study VIA 7.
    Schizophr Res. 2025;279:137-143.
    

    >> Share

    
    
22. RETHA S, Hilmar L, Lebogang P, Sanja K, et al
    Corrigendum to "Psychopathology trajectories and relapse in first episode schizophrenia with assured long-acting injectable adherence over 24 months" [Schizophr. Res. volume 276 (2025), 8-14/article number].
    Schizophr Res. 2025 Apr 5:S0920-9964(25)00125.
    

    >> Share

    
    
23. PALOMINOS C, Kirdun M, Nikzad AH, Spilka MJ, et al
    A single composite index of semantic behavior tracks symptoms of psychosis over time.
    Schizophr Res. 2025;279:116-127.
    

    >> Share

    
    
24. LIU K, Chen HW, Wang SA, Zhang CY, et al
    Association between serum bilirubin and type 2 diabetes mellitus risk: Findings from a schizophrenia cohort.
    Schizophr Res. 2025;279:106-115.
    

    >> Share

    
    
25. CHEN L, Wang Z, Wang Y, Jiang H, et al
    Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective.
    Schizophr Res. 2025;279:94-105.
    

    >> Share

    
    
26. NIELSEN JRW, Dietz M, Jefsen OH
    Blink rates in patients with schizophrenia compared to healthy controls: A meta-analysis.
    Schizophr Res. 2025;279:87-93.
    

    >> Share

    
    
27. YUAN Q, Chen Y, Xu Y, Dimitrov LV, et al
    Cluster profiles of distressing psychotic-like experiences among children and associations with genetic risk, prenatal cannabis exposure, and social-environmental characteristics.
    Schizophr Res. 2025;278:119-127.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share